Clinical Trial Update: Methylphenidate in Myotonic Dystrophy Type 1 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating methylphenidate for myotonic dystrophy type 1 has completed, with Laval University listed as sponsor. No results are provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Laval University | Conditions: Dystrophia Myotonica 1 | Phase 2, Phase 3 | Status: COMPLETED